![Jeffrey D Milbrandt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey D Milbrandt
Fondateur chez Disarm Therapeutics, Inc.
Postes actifs de Jeffrey D Milbrandt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Disarm Therapeutics, Inc.
![]() Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
Fondateur | - | - |
Historique de carrière de Jeffrey D Milbrandt
Anciens postes connus de Jeffrey D Milbrandt
Sociétés | Poste | Début | Fin |
---|---|---|---|
PierianDx, Inc.
![]() PierianDx, Inc. Information Technology ServicesTechnology Services PierianDx, Inc. provides genomic software and services. It develops a platform to manage, analyze, and interpret complex genomic tests for clinical laboratories across the United States. The firm?s genomics software platform, Clinical Genomicist Workstation (CGW), provides data-driven workflow for health systems, academic medical centers, and commercial labs to improve patient outcomes through genomic analysis, interpretation and reporting. The company was founded by Jeffrey D. Milbrandt, Karen Seibert, John D. Pfeifer, Herbert W. Virgin, and Rakesh Nagarajan in 2014 and is headquartered in St. Louis, MO. | Fondateur | 01/01/2014 | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Founder | 2 |
Director/Board Member | 1 |
Sectorielle
Technology Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
PierianDx, Inc.
![]() PierianDx, Inc. Information Technology ServicesTechnology Services PierianDx, Inc. provides genomic software and services. It develops a platform to manage, analyze, and interpret complex genomic tests for clinical laboratories across the United States. The firm?s genomics software platform, Clinical Genomicist Workstation (CGW), provides data-driven workflow for health systems, academic medical centers, and commercial labs to improve patient outcomes through genomic analysis, interpretation and reporting. The company was founded by Jeffrey D. Milbrandt, Karen Seibert, John D. Pfeifer, Herbert W. Virgin, and Rakesh Nagarajan in 2014 and is headquartered in St. Louis, MO. | Technology Services |
Disarm Therapeutics, Inc.
![]() Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Jeffrey D Milbrandt
- Expérience